Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3375238

[Ac+3].[Cl-].[Cl-].[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137822-A1 MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY ABDERA THERAPEUTICS INC (US) 2026-05-21 US disclosed
US-20260055180-A1 KIDNEY TARGETING ANTIBODIES ABDERA THERAPEUTICS INC (US) 2026-02-26 US disclosed
WO-2025244971-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROSTATE CANCER JANSSEN BIOTECH, INC. (US) 2025-11-27 WO disclosed
US-20250340701-A1 DENDRIMER-DELIVERED ALPHA-PARTICLE RADIOTHERAPY FOR TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS IN THE BRAIN UNIV JOHNS HOPKINS (US) 2025-11-06 US disclosed
US-20250270090-A1 LOW TEMPERATURE SYNTHESIS OF MONAZITE-TYPE MATERIALS UNIVERSITY OF SOUTH CAROLINA 2025-08-28 US disclosed
WO-2025151464-A1 ALPHA-PARTICLE RADIONUCLIDE-ANTIBODY CONJUGATES FOR TREATMENT OF SOLID TUMORS THE JOHNS HOPKINS UNIVERSITY (US) 2025-07-17 WO disclosed
EP-4577578-A1 DLL3 BINDING MOLECULES AND USES THEREOF Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
EP-4577526-A1 VHH ANTIBODY CONJUGATES Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
EP-4577576-A1 KIDNEY TARGETING ANTIBODIES Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
EP-4577250-A1 MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
EP-1091757-A2 ALPHA EMITTING CONSTRUCTS AND USES THEREOF Sloan-Kettering Institute For Cancer Research (US) 2001-04-18 EP disclosed
EP-1073609-A2 BISMUTH-213 GENERATOR AND USES THEREOF Sloan-Kettering Institute For Cancer Research (US) 2001-02-07 EP disclosed
WO-1999061097-A9 ALPHA EMITTING CONSTRUCTS AND USES THEREOF SLOAN KETTERING INST CANCER (US) 2000-06-02 WO disclosed
WO-1999061097-A2 ALPHA EMITTING CONSTRUCTS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1999-12-02 WO disclosed
WO-1999049931-A2 BISMUTH-213 GENERATOR AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1999-10-07 WO disclosed
US-4446061-A FIREPROOFING, SMOKELESS, PHOSPHITE/PHOSPHONATE MONSANTO COMPANY (US) 1984-05-01 US disclosed
US-4313761-A FIREPROOFING AND SMOKE SUPPRESSANTS MONSANTO COMPANY (US) 1982-02-02 US disclosed
US-4260542-A FLAME RETARDANTS, SMOKE SUPPRESSANTS MONSANTO COMPANY (US) 1981-04-07 US disclosed
US-4206133-A FLAME RETARDANTS AND SMOKE SUPPRESSANTS MONSANTO COMPANY (US) 1980-06-03 US disclosed
US-4133823-A FIREPROOFING, SMOKELESS MONSANTO COMPANY (US) 1979-01-09 US disclosed